Aptose Biosciences Inc. (NASDAQ:APTO) Sees Large Decline in Short Interest

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 54,900 shares, a decline of 35.9% from the March 31st total of 85,600 shares. Approximately 0.6% of the company’s stock are sold short. Based on […]

Related Keywords

Texas ,United States ,Canada ,Piper Sandler ,Aptose Biosciences ,Aptose Biosciences Inc ,Annandale Capital ,Sigma Planning Corp ,Aptose Biosciences Company Profile ,Nasdaq ,Texas Capital Bank Wealth Management Services Inc ,Get Free Report ,Planning Corp ,Biosciences Inc ,Aptose Biosciences Daily ,Nasdaq Apto ,Dapto ,Medical ,Stocks ,Options ,Put ,Call ,